198 3-month ivacaftor (Kalydeco™) treatment resulted in weight gain, decreased resting energy expenditure and gut inflammation, and increased pulmonary function, muscle mass and strength, and growth status

2016 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []